ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2463
0,00%
Bitcoin
68.120,34
0,58%
Brent Oil
81,295
0,00%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Vyant Bio Inc (VYNT)

  7. Vyant Bio Inc (VYNT) Notícias

VYNT

Vyant Bio (VYNT)

Vyant Bio Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:VYNT
DataHoraFonteTítuloCódigoCompanhia
26/12/202311:15GlobeNewswire Inc.Vyant Bio Provides Update on Winddown ActivitiesNASDAQ:VYNTVyant Bio Inc
01/11/202312:45GlobeNewswire Inc.Vyant Bio Announces Stockholder Approval of Plan of DissolutionNASDAQ:VYNTVyant Bio Inc
24/10/202317:00GlobeNewswire Inc.Vyant Bio Announces Completion of StemoniX Asset SaleNASDAQ:VYNTVyant Bio Inc
19/10/202312:45GlobeNewswire Inc.Vyant Bio Announces Stockholder Approval of Proposed Asset Sale; 64,110 Votes Needed to Approve Plan of Dissolution; and Adjournment of Special Meeting of StockholdersNASDAQ:VYNTVyant Bio Inc
11/10/202312:45GlobeNewswire Inc.Vyant Bio Announces 77,522 Votes Needed to Approve Sale of Assets 175,721 Votes Needed to Approve Winddown of Business Adjournment of Special Meeting of StockholdersNASDAQ:VYNTVyant Bio Inc
28/09/202312:45GlobeNewswire Inc.Vyant Bio Announces Adjournment of Special Meeting of StockholdersNASDAQ:VYNTVyant Bio Inc
31/07/202318:15Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:VYNTVyant Bio Inc
15/05/202309:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:VYNTVyant Bio Inc
12/05/202309:00GlobeNewswire Inc.Vyant Bio Announces Last Day of Trading on Nasdaq and Filing of Form 15 for Voluntary Nasdaq Delisting and SEC DeregistrationNASDAQ:VYNTVyant Bio Inc
10/05/202309:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VYNTVyant Bio Inc
04/05/202317:33Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)NASDAQ:VYNTVyant Bio Inc
04/05/202317:30GlobeNewswire Inc.Vyant Bio Announces Filing of Form 25 for Voluntary Nasdaq Delisting and SEC DeregistrationNASDAQ:VYNTVyant Bio Inc
24/04/202317:50GlobeNewswire Inc.Vyant Bio Announces Voluntary Nasdaq Delisting and SEC DeregistrationNASDAQ:VYNTVyant Bio Inc
28/03/202307:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:VYNTVyant Bio Inc
24/03/202310:05Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:VYNTVyant Bio Inc
24/03/202309:35Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:VYNTVyant Bio Inc
03/02/202308:00GlobeNewswire Inc.Vyant Bio Commences a Cash Preservation Plan Including a Reduction in ForceNASDAQ:VYNTVyant Bio Inc
19/01/202318:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VYNTVyant Bio Inc
04/01/202318:15GlobeNewswire Inc.Vyant Bio Engages LifeSci Capital to Explore Strategic AlternativesNASDAQ:VYNTVyant Bio Inc
17/11/202208:20TipRanksAnalysts Are Bullish on These Healthcare Stocks: Vyant Bio (VYNT), Cybin (CYBN)NASDAQ:VYNTVyant Bio Inc
16/11/202219:05GlobeNewswire Inc.Vyant Bio Presents Key Takeaways from Platform and Poster Presentations at Neuroscience 2022 Hosted by the Society for NeuroscienceNASDAQ:VYNTVyant Bio Inc
16/11/202218:43GlobeNewswire Inc.Vyant Bio Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:VYNTVyant Bio Inc
15/11/202210:00GlobeNewswire Inc.Vyant Bio Reports Third Quarter 2022 Results and Provides Strategic and Business HighlightsNASDAQ:VYNTVyant Bio Inc
14/11/202218:46Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VYNTVyant Bio Inc
10/11/202219:13GlobeNewswire Inc.Vyant Bio Presents Key Takeaways from Platform and Poster Presentations at the 2022 CDKL5 Forum Hosted by the Loulou FoundationNASDAQ:VYNTVyant Bio Inc
10/11/202210:00GlobeNewswire Inc.Vyant Bio to Participate at Neuroscience 2022, the 52nd Annual Gathering of the Society for Neuroscience, on November 12-16NASDAQ:VYNTVyant Bio Inc
07/11/202211:00GlobeNewswire Inc.Vyant Bio Teams Up with the International Rett Syndrome Foundation to Host Local Viewing Party in Honor of the 3rd Annual ‘Raise a Glass for Rett Gala’NASDAQ:VYNTVyant Bio Inc
04/11/202207:10TipRanksAnalysts Are Bullish on These Healthcare Stocks: Vyant Bio (VYNT), Kymera Therapeutics (KYMR)NASDAQ:VYNTVyant Bio Inc
03/11/202210:10GlobeNewswire Inc.Reaction Biology and Vyant Bio Announce Closing of Definitive Agreement to Acquire U.S. Operations of Vyant Bio, Inc. SubsidiaryNASDAQ:VYNTVyant Bio Inc
01/11/202209:00GlobeNewswire Inc.Vyant Bio Announces One-for-Five Reverse Stock SplitNASDAQ:VYNTVyant Bio Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:VYNT

Seu Histórico Recente

USOTC
FUNN
Amfil Technologies (PK)
EU
FR0011635093
Auto ABS German Loans Ma...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados